Bayer Korea researches, develops, manufactures and markets innovative products for the prevention, diagnosis and treatment of diseases. The company plays an important role in improving the health of people and animals. This subgroup comprises Pharmaceuticals, Madical Care.
Booth No. D017
Lunchtime Activities | |
Evolving Role of Anticoagulant in Acute Coronary Syndrome | |
Organized by CVRF and Supported by Educational Grant from Bayer Korea | |
Wednesday, April 26 12:45 PM - 1:45 PM Room 1A, Level 3 |
|
Moderator(s): In-Ho Chae | |
Panelist(s): Sang-Rok Lee, Kyung Woo Park, Young Bin Song | |
12:45 PM | Changing Antithrombotic Strategy in Acute Coronary Syndrome
Lecturer : Jung-Sun Kim
|
1:05 PM | Optimal Antithrombotic Treatment in Patients with AF Undergoing PCI
Lecturer : Freek W.A. Verheugt
|
1:25 PM | Panel Discussion |